Mobile

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-017591-24

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of the study is to evaluate the anti-tumor activity of LY2181308 in combination with docetaxel therapy (experimental arm) compared to docetaxel alone (control or standard-of-care arm) in second line Non Small Cell Lung Cancer (NSCLC) patients.

Critère d'inclusion

  • Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Liens